APC and colorectal carcinoma: In CRC, AP-2α interacts with the adenomatous polyposis coli (APC) protein, converting nuclear β-catenin into an inactive form, further reducing its association with the TCF/LEF transcription factors, ultimately disrupting the Wnt/β-catenin pathway and inhibiting EMT progression [27].